efavirenz has been researched along with Adverse Drug Event in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 2 (6.67) | 29.6817 |
| 2010's | 23 (76.67) | 24.3611 |
| 2020's | 4 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Abidin, ZZ; Chidambaram, SK; Fahrni, ML; Lazzarino, AI; Misran, NFL | 1 |
| Braga, MDG; Mendes, JC; Reis, AMM; Silveira, MR | 1 |
| Bula, A; Chagomerana, M; Chapola, JC; Hosseinipour, MC; Lee, F; Rosenberg, NE; Tang, JH; Tseka, J | 1 |
| Dai, L; Li, J; Liu, A; Mahajan, SD; Schwartz, SA; Scott, SR; Shao, Y; Su, B; Sun, L; Wu, H; Ye, J; Yu, H; Zhang, H; Zhang, T | 1 |
| Brasher, WP; Bvumbwe, M; Kazembe, PN | 1 |
| Aplenc, R; Bellamy, SL; Bisson, GP; Gross, R; Han, X; Moorthy, G; Mosepele, M; Ratshaa, B; Steenhoff, AP; Strom, BL; Vujkovic, M; Zuppa, AF | 1 |
| Foster, C; Lyall, H; Tudor-Williams, G; Williams, E; Wynberg, E | 1 |
| Bonolo, PF; Ceccato, MDGB; Costa, JO; Dos Santos, H; Mendes, JC; Reis, AMM; Silveira, MR | 1 |
| Baker, P; Cardoso, CC; da Silva, GAR; de Almeida, TB; de Azevedo, MCVM; de Castro, IJ; Ferry, FRA; Haas, DW; Pinto, JFDC; Tanuri, A | 1 |
| Boulle, A; Cohen, K; Davies, MA; de Waal, R; Fox, MP; Igumbor, EU; Maartens, G | 1 |
| Sukasem, C; Sungkanuparph, S | 1 |
| Botes, M; Burnside, R; Clumeck, N; Cooper, DA; Dejesus, E; Heera, J; Ive, P; Lazzarin, A; Mukwaya, G; Saag, M; van Der Ryst, E; Walmsley, S | 1 |
| De Castro, N; Delaugerre, C; Flandre, P; Gallien, S; Molina, JM; Nguyen, N | 1 |
| Dodderi, SK; Govindaraj, M; Pavithra, HB; Premalatha, R; Rewari, BB; Sanjeeva, GN; Shivananda, S; Sukanya, V | 1 |
| Aurpibul, L; Chokephaibulkit, K; Cressey, TR; Phongsamart, W; Sirisanthana, V; Sricharoenchai, S; Sudjaritruk, T; Wittawatmongkol, O | 1 |
| Clotet, B; Cruceta, A; Curran, A; Domingo, P; Ferrer, E; Gatell, JM; Guardo, AC; Loncà, M; Lozano, F; Manzardo, C; Miro, JM; Pérez, I; Plana, M; Podzamczer, D | 1 |
| Antinori, A; Arribas, JR; Bloch, M; Bosse, M; Chuck, SK; Cohen, CJ; De-Oertel, S; Garner, W; Piontkowsky, D; Porter, D; Rachlis, A; Rieger, A; Segal-Maurer, S; van Lunzen, J; Wohl, DA | 1 |
| Beanland, R; Doherty, M; Lackey, M; Li, H; Ma, Q; Ma, W; Marley, G; Renaud, F; Tucker, JD; Vitoria, M; Wei, C | 1 |
| Chêne, G; Gallien, S; Journot, V; Loriot, MA; Molina, JM; Morlat, P; Reliquet, V; Reynes, J; Sauvageon, H | 1 |
| Bentley, TGK; Broder, MS; Chang, E; Myers, J; Papoyan, E; Reddy, SR; Rosenblatt, L | 1 |
| Bele, V; Dravid, A; Gupte, N; Joshi, K; Pujari, S | 1 |
| Dudas, K; Dumont, E; Kim, J; Lou, Y; Mayers, D; Pietropaolo, K; Piscitelli, S; St Clair, M; White, S; Zala, C; Zhou, XJ | 1 |
| Agu, KA; Akpoigbe, KJ; Badru, T; Chabikuli, O; Eluwa, GI; Hamelmann, C | 1 |
| Amaya, G; Arns da Cunha, C; Boven, K; Buelens, A; Clumeck, N; Jayaweera, D; Junod, P; Li, T; Nelson, M; Stevens, M; Tebas, P; Vanveggel, S | 1 |
| Chersich, M; Fairlie, L; Kuhn, L; Meyers, T; Moultrie, H; Palmer, M | 1 |
| Boven, K; Cassetti, I; Chetchotisakd, P; Cohen, CJ; Crauwels, H; Lazzarin, A; Li, T; Molina, JM; Orkin, C; Rhame, F; Rimsky, L; Stellbrink, HJ; Vanveggel, S; Williams, P | 1 |
| Ainsworth, JG; Haddow, LJ; Wood, CW | 1 |
| Hussar, DA | 1 |
1 review(s) available for efavirenz and Adverse Drug Event
| Article | Year |
|---|---|
The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis.
Topics: Adaptation, Psychological; Alkynes; Anti-HIV Agents; Benzoxazines; Counseling; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Medication Adherence; Qualitative Research | 2017 |
8 trial(s) available for efavirenz and Adverse Drug Event
| Article | Year |
|---|---|
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclohexanes; Cyclopropanes; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Male; Maraviroc; Middle Aged; Treatment Outcome; Triazoles; Viral Load; Young Adult | 2014 |
Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial).
Topics: Adult; Aged; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Plasma; Ritonavir; RNA, Viral; Survival Analysis; Treatment Outcome; Viral Load; Young Adult | 2015 |
Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Resistance, Viral; Drug-Related Side Effects and Adverse Reactions; Female; HIV-1; Humans; Male; Middle Aged; Quality of Life; Rilpivirine; RNA, Viral; Tablets; Treatment Outcome; Viral Load | 2016 |
Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Genetic Predisposition to Disease; HIV Infections; Humans; Male; Middle Aged; Plasma; Polymorphism, Single Nucleotide | 2017 |
Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India.
Topics: Adenine; Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Drugs, Generic; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; India; Male; Middle Aged; Organophosphonates; Prevalence; Tenofovir; Treatment Outcome; Young Adult | 2008 |
Safety and efficacy of GSK2248761, a next-generation nonnucleoside reverse transcriptase inhibitor, in treatment-naive HIV-1-infected subjects.
Topics: Adult; Alkynes; Anti-HIV Agents; Argentina; Benzoxazines; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Viral; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Male; Mutation; Phosphinic Acids; Placebos; Reverse Transcriptase Inhibitors; Viral Load | 2012 |
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkynes; Animals; Antiviral Agents; Aspartate Aminotransferases; Benzoxazines; Coinfection; Cyclopropanes; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis C Antibodies; HIV Infections; HIV-1; Humans; Liver; Liver Function Tests; Male; Middle Aged; Nitriles; Placebos; Pyrimidines; Rilpivirine; Treatment Outcome; Young Adult | 2012 |
Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nitriles; Pyrimidines; Rilpivirine; Treatment Outcome; Young Adult | 2013 |
21 other study(ies) available for efavirenz and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Clinical predictors of efavirenz-based regimen treatment durability: A two-year case-control study of antiretroviral-naïve patients.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Opportunistic Infections; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome; Viral Load | 2023 |
Neuropsychiatric adverse drug reactions and associated factors in a cohort of individuals starting dolutegravir-based or efavirenz-based antiretroviral therapy in Belo Horizonte, Brazil.
Topics: Benzoxazines; Brazil; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Prospective Studies | 2023 |
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV.
Topics: Anti-Retroviral Agents; Benzoxazines; Counseling; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans | 2023 |
Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naïve Patients in Beijing: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Asian People; Beijing; Benzoxazines; Case-Control Studies; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Dyslipidemias; Female; HIV Infections; Hospitals, University; Humans; Lipids; Lopinavir; Male; Middle Aged; Retrospective Studies; Ritonavir; Treatment Outcome | 2019 |
Infection or drug toxicity? Acute ataxia and encephalopathy after uncomplicated falciparum malaria and efavirenz dose adjustment.
Topics: Adolescent; Alkynes; Antiretroviral Therapy, Highly Active; Ataxia; Benzoxazines; Brain Diseases; Cyclopropanes; Diplopia; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Malaria, Falciparum; Plasmodium falciparum; Reverse Transcriptase Inhibitors | 2020 |
CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana.
Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Botswana; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Genotyping Techniques; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; RNA, Viral; Surveys and Questionnaires; Survival Analysis; Treatment Outcome; Viral Load; Young Adult | 2017 |
Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?
Topics: Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; Body Weight; CD4 Lymphocyte Count; Child; Cyclopropanes; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Failure; Viral Load | 2018 |
Adverse reactions associated with first-line regimens in patient initiating antiretroviral therapy.
Topics: Adolescent; Adult; Aged; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Brazil; Cross-Sectional Studies; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Prospective Studies; Pyridones; Quality of Life; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult | 2018 |
Drug metabolism and transport gene polymorphisms and efavirenz adverse effects in Brazilian HIV-positive individuals.
Topics: Adult; Aged; Alkynes; Benzoxazines; Brazil; Constitutive Androstane Receptor; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Female; Genetic Association Studies; HIV Infections; Humans; Inactivation, Metabolic; Male; Middle Aged; Polymorphism, Genetic; Reverse Transcriptase Inhibitors | 2018 |
Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Kaplan-Meier Estimate; Retrospective Studies; South Africa; Stavudine; Tenofovir | 2018 |
Would a CYP2B6 test help HIV patients being treated with efavirenz?
Topics: Alkynes; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Central Nervous System; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug-Related Side Effects and Adverse Reactions; Genotype; HIV; HIV Infections; Humans; Polymorphism, Single Nucleotide; Treatment Outcome | 2013 |
Safety and efficacy of coformulated efavirenz/emtricitabine/tenofovir single-tablet regimen in treatment-naive patients infected with HIV-1.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Emtricitabine; Europe; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Plasma; Tablets; Tenofovir; Treatment Outcome; Viral Load | 2015 |
Nevirapine-related adverse events among children switched from efavirenz to nevirapine as compared to children who were started on nevirapine-based antiretroviral therapy directly.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Drug Administration Schedule; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Incidence; India; Male; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome | 2015 |
Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing.
Topics: Adenine; Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; Bone Density; Calcium; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Organophosphonates; Prospective Studies; RNA, Viral; Tenofovir; Treatment Outcome; Urinalysis; Viral Load | 2015 |
Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users: analysis of patient electronic medical record data.
Topics: Adult; Alkynes; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Electronic Health Records; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Young Adult | 2017 |
Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Organophosphonates; Pain; Retrospective Studies; Risk Factors; Stavudine; Tenofovir; Zidovudine | 2012 |
Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Retrospective Studies; Risk Factors; South Africa; Stavudine; Time Factors | 2013 |
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitor-related metabolic toxicity.
Topics: Adolescent; Adult; Aged; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; United Kingdom | 2007 |
New drugs 99, Part III.
Topics: Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antiviral Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Monitoring; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Etidronic Acid; Humans; Infliximab; Leprostatic Agents; Osteitis Deformans; Oxazines; Rifampin; Risedronic Acid; Thalidomide; Thionucleotides; Trastuzumab | 1999 |